Efgartigimod Alfa-Fcab

DRUG2 trials

Sponsors

Chafic Karam, Beijing Tiantan Hospital

Conditions

Guillain-Barre SyndromeGuillain-Barré Syndrome

Phase 2

Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome

WithdrawnNCT05701189

Chafic KaramGuillain-Barre Syndrome

Start: 2024-09-10End: 2026-02-20Updated: 2026-03-12

Efficacy and Safety of Efgartigimod in the Treatment of Guillain-Barré Syndrome(GREAT)

Not yet recruitingNCT07806916

Beijing Tiantan HospitalGuillain-Barré Syndrome

Start: 2026-09-01End: 2027-12-01Target: 110Updated: 2026-09-08